Pay in 4 interest-free payments of $5.71 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
If left untreated, they may progress to coma and death
Oral GLP-1 pills are now offering an excellent alternative for those who prefer a daily tablet over an injection
Ro exited compounded GLP-1s in 2026 amid FDA enforcement pressure on the category Brand-name Wegovy oral pill (FDA-approved semaglutide) $149/month first month, rising to $199$299/month at higher ongoing doses Brand-name Wegovy injection/pen (FDA-approved) $199/month first month, rising to $199$399/month ongoing Brand-name Zepbound KwikPen (FDA-approved tirzepatide) $299/month first month, rising to $399$449/month ongoing Brand-name Ozempic (FDA-approved semaglutide for type 2 diabetes) insurance-dependent pricing (not independently verified this sweep) Important compliance note on compounded products Compounded semaglutide and compounded tirzepatide whether obtained through Cora Health or other telehealth platforms that offer compounded medication are not FDA-approved and are not therapeutically equivalent to FDA-approved branded products (Ozempic, Wegovy, Mounjaro, Zepbound)
Keep tightly closed in a dry place
Frequently asked questions Frequently asked questions about the GHK-Cu Capsules
Each consultation reinforces the importance of urgency and progress
